Sequenom Inc. (Nasdaq: SQNM) widened losses for the third quarter to 26 cents per share from 19 cents per share a year earlier but revenue soared and sales of its Down syndrome test is expected to exceed expectations. The stock price climbed 57 cents to close at $3.60.